Fusid B Cream
Betamethasone 0.1% + Fusidic Acid 2% Topical
0.1% w/w + 2% w/w
Quest Pharmaceuticals Pvt. Ltd.
Pack size | |
---|---|
Dispensing mode | |
Source | |
Agent | |
Retail Price | 115.00 NPR |
Indications
Fusid B Cream is used for:
Lichen planus, Psoriasis, Eczema, Contact dermatitis, Seborrhoeic dermatitis, Systemic lupus erythematosus, Lichen simplex, Prurigo nodularis, Sunburns
Adult Dose
Adult: Topical As cream: Apply twice daily. Usual duration: Up to 2 wk/course.
Child Dose
Renal Dose
Administration
Contra Indications
Skin lesions of viral, fungal or bacterial origin, acne rosacea and perioral dermatitis.
Precautions
Avoid prolonged continuous treatment especially in infants and children. Extended treatment may increase the risk of contact sensitisation and development of antibiotic resistance. Not to be used for >7 days if there is no clinical improvement. Increased risk of glaucoma if preparation enters the eye(s). Pregnancy and lactation.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Betamethasone 0.1% + Fusidic Acid 2% Topical :
Prolonged intensive treatment may cause local atrophic changes in the skin e.g. striae, thining and dilatation of superficial blood vessels. Dryness, itching, irritation, hypopigmentation, burning sensation at the site of application or miliaria.
Mechanism of Action
Betamethasone valerate is a topical corticosteroid that is effective in inflammatory dermatoses. Topical fusidic acid is effective against Staphyloccus aureus, Streptococci, Corynebacteria, Neisseria and some Clostridia and bacteroides. Antibacterial activity of fusidic acid is not reduced when used with betamethasone.
Note
Fusid B 0.1% w/w + 2% w/w Cream manufactured by Quest Pharmaceuticals Pvt. Ltd.. Its generic name is Betamethasone 0.1% + Fusidic Acid 2% Topical. Fusid B is availble in Nepal.
Farmaco Nepal drug index information on Fusid B Cream is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.